Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Medical devices should be brought under price control: SJM

      Medical devices should be brought under price control: SJM

      Medical Dialogues Bureau9 Feb 2018 10:45 AM IST
      New Delhi: The RSS-affiliated SJM has requested Prime Minister Narendra Modi to immediately bring 19 categories of medical devices such as hip...
      Data science ushering in next wave of drug innovation: Kiran Mazumdar-Shaw

      Data science ushering in next wave of drug innovation: Kiran Mazumdar-Shaw

      Medical Dialogues Bureau8 Feb 2018 10:00 AM IST
      New Delhi: Biocon CMD Kiran Mazumdar-Shaw said data science is ushering in the next wave of drug innovations by promising to transform every stage of...
      Billionaire doctor buys LA news paper for 500 million dollars

      Billionaire doctor buys LA news paper for 500 million dollars

      Medical Dialogues Bureau8 Feb 2018 9:15 AM IST
      Los Angeles: A billionaire doctor struck a USD 500 million deal to buy the Los Angeles Times, ending the paper's quarrelsome relationship with its...
      Natco Pharma Q3 net profit up 12 percent at Rs 217.4 crore

      Natco Pharma Q3 net profit up 12 percent at Rs 217.4 crore

      Medical Dialogues Bureau7 Feb 2018 10:30 AM IST
      New Delhi: Drug firm Natco Pharma reported an 11.54 percent rise in its consolidated profit after tax at Rs 217.4 crore for the quarter ended December...
      Healthi raises USD 3.1 million to accelerate business growth, development

      Healthi raises USD 3.1 million to accelerate business growth, development

      Medical Dialogues Bureau7 Feb 2018 10:13 AM IST
      New Delhi: Healthi, a digital preventive health startup announced raising funding to the tune of USD 3.1 million to accelerate business growth and...
      Jubilant receives ANDA approval for Clonidine Hydrochloride ER Tablets

      Jubilant receives ANDA approval for Clonidine Hydrochloride ER Tablets

      Medical Dialogues Bureau1 Feb 2018 10:30 AM IST
      Jubilant Life Sciences has announced that its material wholly owned subsidiary Jubilant Pharma Limited has received Abbreviated New Drug Application...
      Maharashtra government dept told to buy medicines from Haffkine

      Maharashtra government dept told to buy medicines from Haffkine

      Medical Dialogues Bureau1 Feb 2018 10:15 AM IST
      Mumbai: The Maharashtra government today made it mandatory for all its departments that provide medical services to purchase medicines, allied...
      Strides Shasun arm gets USFDA nod for HIV drug

      Strides Shasun arm gets USFDA nod for HIV drug

      Medical Dialogues Bureau30 Jan 2018 11:00 AM IST
      New Delhi: Pharmaceutical company Strides Shasun said its wholly-owned subsidiary has received approval from the US health regulator for tenofovir...
      AstraZeneca

      AstraZeneca's three in one inhaler helps COPD patients in trial

      Medical Dialogues Bureau30 Jan 2018 9:45 AM IST
      AstraZeneca said an inhaler for chronic obstructive pulmonary disease delivered improved lung function in a late-stage trial that could challenge...
      Abbott to take a pause after deal spree

      Abbott to take a pause after deal spree

      Medical Dialogues Bureau30 Jan 2018 9:30 AM IST
      Abbott Laboratories said it was not looking at acquisitions this year as the healthcare company looks to ease its debt burden after a spree of deals...
      Cipla gets USFDA approval for HIV drug

      Cipla gets USFDA approval for HIV drug

      Medical Dialogues Bureau29 Jan 2018 1:40 PM IST
      New Delhi: Drug major Cipla said it has received final approval from the US health regulator for tenofovir disoproxil fumarate tablets, used to treat...
      Budget 2018 Forecast : Import duty hike on some medical devices likely

      Budget 2018 Forecast : Import duty hike on some medical devices likely

      Medical Dialogues Bureau29 Jan 2018 1:26 PM IST
      NEW DELHI: The government may consider increasing import duty on certain medical devices in the forthcoming Budget with an aim to boost domestic...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok